Amir H. Hamrahian, MD, is Chief of Endocrinology in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi. He specializes in Endocrinology, Diabetes, and Metabolism.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Hamrahian served as the Director of Clinical Research at the Endocrinology and Metabolism Institute, and the Director of the Endocrinology Fellowship Program at US-based Cleveland Clinic.
He specializes in Endocrinology, Diabetes, and Metabolism and has special interests in pituitary and adrenal disorders. Dr. Hamrahian has published more than 65 peer reviewed articles, along with more than 70 abstracts and book chapters. He has given presentations on pituitary and adrenal disorders at national meetings of the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) annual meetings. He served as co-author on AACE adrenal incidentaloma, cushing and acromegaly guidelines, and has participated in the international consensus conferences on diagnosis and management of acromegaly. He has served as the principal investigator for a number of pituitary-related clinical research studies. He initiated and co-directed an annual Pituitary Day Conference in Cleveland from 2005 to 2014.
Dr. Hamrahian received his medical degree from Hacettepe University in Ankara, Turkey. He completed his Internal Medicine residency at the University of North Dakota in Fargo, North Dakota and his fellowship in Endocrinology at Case Western Reserve University in Cleveland, Ohio.